GAD2 and type 1 diabetes mellitus: GAD65, the prototypic T1D autoantigen, can be used to predict the outcome of islet transplantation [1], but its use is limited due to interference by GAD65-autoantibodies and technical limitations of analytical sensitivity of sandwich immunoassay technology [2].